Opens in a new tab
Who Answers
Who Answers
DRS helpline phone number
Who Answers?

Calls to the website’s main helpline are answered by Wert Inc., a call center that specializes in helping individuals and families across the United States find resources for substance use disorder.

Addicted.org and Wert Inc. do not own any rehab or addiction services. This means our helpline can provide completely independent and unbiased advice to help you find the rehab service most suitable for you or your loved one.

Please note that if you are calling from California, your call will be answered by Alli Intervention, an intervention service based in California. However, when calling the helpline, you are under no obligation to use any of their services.

Our helpline comes at no cost to the caller and offers complete confidentiality.

You can also browse our comprehensive list of addiction treatments by state by visiting our homepage. Don’t hesitate to reach out by calling our helpline or filling out our contact form if you need help finding the right rehab center or detox program. However, if you believe you have a medical emergency, you should immediately call 911.

For more information, visit our What Happens When You Call Our Helpline page.

Home › Articles › Addiction Resources › Opioid Addiction Resources › Prescription Opioid Addiction Treatment: Options, Expectations, and Next Steps

Prescription Opioid Addiction Treatment: Options, Expectations, and Next Steps

Prescription opioid addiction and heroin addiction are both opioid use disorder, and the same medications treat both. What tends to differ is who arrives at treatment. People seeking help for prescription opioid dependence are often earlier in the progression, less likely to have been through treatment or a detox attempt before, and far less likely to have injected.

Many are also managing the pain condition that led to the prescription in the first place. That does not resolve on its own when the addiction is addressed, and treatment has to account for both.

This page explains what treatment options exist, how medications fit into the picture, and what tends to be different about people who came to opioids through a prescription.

Treatment Settings: Levels of Care

Treatment is delivered at different levels of intensity depending on clinical need. NIDA describes opioid treatment programs as residential or outpatient facilities that usually combine medication with behavioral therapies. The right starting point depends on an honest assessment of severity, support at home, and prior treatment history.

Medically Supervised Withdrawal (Medical Detox)

For people with physical dependence, withdrawal can be managed with clinical supervision, where staff monitor symptoms and vital signs. For many people this is the entry point into treatment, and getting through withdrawal safely is what makes the work that follows possible. It is worth being clear on one point, though: withdrawal management is not by itself treatment for opioid use disorder. It is also not the only way in. Buprenorphine is started when a person is already in withdrawal rather than after a completed detox, and methadone treatment does not require one either. What determines the outcome is not which door someone comes through, but whether something follows.

This matters because of what happens to tolerance. MedlinePlus notes that opioid withdrawal symptoms are very uncomfortable but not life threatening, and that the biggest complication is returning to drug use. Most opioid overdose deaths occur in people who have just detoxed, because withdrawal reduces tolerance and a much smaller dose than before can then be fatal. StatPearls reports that patients are at highest risk for opioid-related death in the first four weeks of treatment and for four weeks after treatment ends. Transitions are where the risk sits, which is why changes in treatment, including reducing or stopping medication, are planned with a prescriber rather than made abruptly.

What follows withdrawal management matters more than the withdrawal itself. The handoff into ongoing care is the point where the risk is concentrated.

Residential Treatment (Inpatient Rehab)

Live-in treatment at a facility. NIDA describes residential programs as extended care lasting from a few weeks to a few months, with longer stays also available, and inpatient care as an overnight hospital or clinic stay for people who need 24-hour support. Residential settings provide structured daily programming, individual and group therapy. They suit people with severe dependence, unstable home environments, co-occurring mental health conditions, or previous outpatient attempts that did not hold. Being away from the drug supply during early recovery is part of what the setting offers.

Partial Hospitalization (PHP)

Structured programming during the day, with patients returning home or to sober living in the evenings. It offers intensive support without a residential stay, and is commonly used as a step-down after inpatient treatment or as a starting point for people with a stable home environment.

Intensive Outpatient (IOP)

A SAMHSA treatment improvement protocol on intensive outpatient treatment cites the American Society of Addiction Medicine definition of nine hours of treatment per week for adults, and notes that these programs generally provide nine hours or more spread over three to five days. Some provide fewer, and the protocol’s consensus panel recommends 6 to 30 hours depending on the person’s needs. This level allows people to maintain work, school and family responsibilities while in meaningful treatment. It is a common step-down from PHP or residential care, and a reasonable primary option for people with moderate dependence and strong support at home.

Standard Outpatient

Regular office or telehealth visits for counseling, medication support, or both. This level generally suits someone who has already stabilized, rather than serving as the whole of treatment during active dependence.

Aftercare and Ongoing Support

Formal treatment ends. The work of staying well does not, and what happens in the months after a program is often what determines whether it holds. NIDA describes mutual help groups as peer-led recovery organizations that connect people with peers who are in recovery, and notes that they are free, not time-limited, and that many people find them useful on their own or alongside professional care. Residential programs typically include referrals to continuing care at discharge, and it is worth asking about those referrals before discharge rather than after.

Research on current treatment approaches points to community-based resources, including peer support meetings and therapeutic housing, as important parts of recovery alongside medical treatment. Narcotics Anonymous and similar programs, group therapy and continued individual counseling all serve the same purpose, which is keeping a person connected to something after the structure of a program goes away.

A relapse prevention plan is worth writing down while still in treatment, when things are stable and thinking is clear. It identifies the situations, people and states of mind that carry the most risk, and names what to do and who to call when one of them shows up. NIDA notes that people may require long-term or multiple episodes of treatment to reach long-term recovery, so a plan that assumes a rough patch is possible is more useful than one that assumes it is not.

For anyone still taking medication at this stage, this is also the period where a plan for eventually coming off it takes shape, made with the prescriber over time rather than decided alone.

Behavioral Therapies

Behavioral therapies address the psychological and situational patterns that drive continued opioid use. They are not tied to one level of care. Whether someone is in a residential program or seeing a counselor once a week, these are the approaches being used.

Our view is that this is where the substance of treatment sits. Medication quiets withdrawal and cravings so a person can function, but it does not touch the reasons someone used in the first place. Therapy does.

Cognitive Behavioral Therapy (CBT)

Identifies thought patterns, emotional triggers and situational cues that lead to opioid use, and builds practical strategies to interrupt them. NIDA describes it as helping people gain control of the stressful emotions and thoughts that lead them to want to take drugs. Particularly relevant for people whose use became tied to pain, stress or difficult emotional states.

There is some evidence it matters more for this group specifically. In a randomized trial of primary care buprenorphine treatment, patients whose primary opioid was a prescription medication and who received CBT alongside physician management averaged 7.6 weeks with urine samples negative for all drugs, compared with 3.6 weeks for those receiving physician management alone. Patients whose primary opioid was heroin showed no such difference. The effect was small to medium, the groups did not differ in how long they stayed in treatment, and the authors call for the finding to be replicated.

Contingency Management

Uses small structured incentives, such as prizes or gift cards, to reinforce drug-free behavior. NIDA notes it is especially effective for addiction to stimulants such as cocaine and methamphetamine, and it is used in opioid treatment as well.

Motivational Enhancement Therapy

A short-term approach that helps people build their own resolve to stop using. Useful when ambivalence is high, which is common among people who began taking opioids for legitimate pain and find it hard to separate that history from the addiction.

Individual, Group, and Family Counseling

Addresses the relational and emotional consequences of addiction. Family involvement is especially relevant where family members have been involved in managing the prescription, or where trust has been damaged.

The Co-Occurring Pain Complication

Many people being treated for prescription opioid addiction have a real underlying pain condition, the reason the opioid was prescribed in the first place. That condition does not go away because the addiction is being addressed, and treatment that ignores it tends not to hold. Both need attention at the same time. In practice that means:

  • Assessment of the underlying pain condition, ideally coordinated between the treating physician and the addiction treatment team
  • Moving to non-opioid pain management where it is clinically workable. The CDC lists options including acetaminophen, ibuprofen and naproxen, certain medications used for depression or seizures, exercise therapy including physical therapy, weight loss, interventional therapies such as injections, cognitive behavioral therapy, acupuncture and massage, and notes that some of these may work better for certain conditions with fewer risks and side effects
  • An honest conversation with the treating physician about the risks of returning to opioid pain management after treatment for opioid use disorder
→
Clinical Note: Increased sensitivity to pain is listed by the CDC among the side effects of prescription opioids. It means pain can feel more severe during and after withdrawal than it did before opioid treatment began, even when nothing about the original condition has changed. It is worth naming this in advance with a physician, so that a spike in pain during withdrawal is understood for what it is rather than taken as proof that the opioid was the only thing that worked.

How This Population Differs from Long-Term Heroin Users

The medications and behavioral approaches are the same either way. What differs is who walks in the door.

In a randomized trial of primary care buprenorphine treatment, patients whose primary opioid was a prescription medication differed from patients whose primary opioid was heroin in a few ways:

  • Two percent reported injection use, compared with 47 percent of the heroin group
  • 24 percent had attempted a previous detoxification, compared with 63 percent
  • 49 percent had had previous drug treatment of another kind, compared with 74 percent
  • CBT added to physician management improved one measure of abstinence for this group, while showing no such benefit for the heroin group

Two other differences pointed the same way but were smaller and did not reach statistical significance: the prescription opioid group had somewhat fewer years of opioid use and were somewhat more likely to be employed full time.

The authors suggest this group may have less severe opioid use disorder, or may be reaching treatment earlier. Their review of earlier research notes that prescription opioid patients have been retained in treatment longer and have had greater opioid abstinence than heroin patients. In this particular trial, though, the two groups did not differ in how long they stayed in treatment or how likely they were to complete it.

Alongside all of this sits the pain question. Someone who came to opioids through a prescription usually still has the condition that prompted it, and treatment has to account for that in a way it does not for someone whose use never began in a doctor’s office.

Deciding Where to Start

There is no single correct entry point. Someone with a stable home and a shorter history may do well beginning at an outpatient level, while someone whose living situation works against recovery may need to be somewhere else for a while. What matters more than the label on the program is whether the pieces connect: that withdrawal management leads into ongoing care rather than ending there, that therapy is the center of the plan rather than something bolted onto it, and that the pain condition is addressed alongside the addiction rather than left for afterward.

On medication, our position is straightforward. Medications for opioid use disorder are the standard of care and they reduce the risk of overdose death. Nobody should be talked out of starting them, and nobody should feel judged for being on them. Our view is that they work best as a bridge rather than a permanent arrangement, quieting withdrawal and cravings so that the underlying work can happen, with the goal of eventually not needing them to get through a day. Rehabilitation, in the plain sense of the word, means being restored to a drug-free state, and for people who want that and can get there safely, it is worth working toward. Any step down is planned with the prescriber, over time, never alone, because tolerance falls quickly and stopping too soon carries real risk.

If you are trying to work out whether it is time to ask about treatment, that question is worth bringing to a physician, a counselor, or a treatment or community program while you are still asking it, rather than waiting until the answer is obvious.

Continue Reading